Mohammed Ali, Boehringer Ingelheim Pharmaceuticals, Inc.

Mohammed Ali Mohammed (Mo) Ali, is the global head for digital development, Global Clinical Operations. He is responsible for the operational execution of the digital development strategy within medicine for Boehringer Ingelheim. He is passionate about digital health and is an evangelist for the advocacy of digital solutions within the patient care and drug development paradigm. His mission is help create alongside his industry peers a closed loop system of digital data driven drug development where the voice of the customer – the patient, the caretaker and the HCP takes center stage in ensuring the best point of care solutions are available for every part of the disease management lifecycle. Previously to joining Boehringer Ingelheim, he has held positions with increasing responsibilities within J&J, Novartis, Roche and Fresenius Healthcare. Mr. Ali has a background in pharmacology and lives with his family in NJ.

Session

1:40 PM - 2:05 PM

Realizing the Potential of Virtual and Hybrid Clinical Trials

The need to increase the speed of patient recruitment, improve retention, and enhance data quality – all while lowering costs, has led to the current interest in virtual and hybrid clinical trials. The question is, how do you know when a virtual or hybrid study makes sense? This session will focus on the critical differences between traditional and virtual or hybrid trials that need to be considered.

  • What therapeutic areas are most effective using virtual and hybrid trials?
  • The importance of protocol design and a distribution and tracking plan for medication.
  • What steps need to be taken to ensure the safety of patients?
  • If the home is the new trial site, how is that different? What do you need to do differently from the start of the process through the end of the trial?
  • Understanding How Digital Therapeutics Will Change the Clinical Trial Paradigm.

Moderator

  • Nitin Naik

    Nitin Naik Vice President-Global Life Sciences, Transformational Health Frost & Sullivan

Speaker

  • Mohammed Ali

    Mohammed Ali Global Head Digital Trials- Global Clinical Operations Boehringer Ingelheim Pharmaceuticals, Inc.


3:05 PM - 3:55 PM

Clinical Development

  • Mohammed Ali

    Mohammed Ali Global Head Digital Trials- Global Clinical Operations Boehringer Ingelheim Pharmaceuticals, Inc.


Download Latest Agenda